NASDAQ:MASI (Masimo)

About MASI

Masimo is an Irvine, California-based medical device business that focuses on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue globally, with the United States the largest market (67% of 2020 sales), followed by Europe, the Middle East, and Africa (21%), Asia and Australia (9%), and North and South America excluding the U.S. (3%).
  • ‘Cost of living crisis’ triggers hidden opportunity?

    While investors rave about Apple, Google and Amazon, this lesser-known stock has quietly grown 880% over the past 5 years. Its compounded revenue growth also beats all of them! And we think it’s only getting warmed up.

    Every month, it reaches 313 million online users – helping many to shop around and save. Now, with the ‘cost of living crisis’, we believe its influence could soar – potentially triggering imminent new gains.

    Discover ‘One Top Growth Stock from The Motley Fool’.

    Grab your FREE report now